Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Genetron Health Announces Receipt Of A Preliminary Non-Binding Proposal From Mr. Sizhen Wang, Co-founder, Chairman Of The Board And Chief Executive Officer Of The Company, To Acquire All Of The Outstanding Ordinary Shares Of The Company For $1.36/ADS

Author: Benzinga Newsdesk | August 22, 2022 06:05am

Posted In: GTH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist